Literature DB >> 8398327

Steroid receptor enhancement by natural interferon-beta in advanced breast cancer.

G Sica1, F Iacopino, G Lama, D Amadori, M Baroni, F Lo Sardo, P Malacarne, P Marchetti, A Pellegrini, A Zaniboni.   

Abstract

In the current study we investigated the effect of two different doses of natural interferon-beta (IFN-beta) on steroid hormone receptors in 45 patients with advanced breast cancer. IFN-beta seems to regulate the receptor mechanisms, inducing in cutaneous metastases an increase of oestrogen and progesterone receptors. Moreover, using IFN-beta and tamoxifen as a combined therapy in 23 receptor-positive patients, no negative interference of the two drugs was observed and no relevant side-effects due to the treatment were noticed. The modulation of steroid receptor content by IFN-beta in advanced breast cancer might represent an interesting way to ameliorate the clinical responsiveness to anti-oestrogens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398327     DOI: 10.1016/0959-8049(93)90378-s

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

Review 1.  Antitumour actions of interferons: implications for cancer therapy.

Authors:  Belinda S Parker; Jai Rautela; Paul J Hertzog
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

2.  Tamoxifen and interferon-beta for the treatment of metastatic breast cancer.

Authors:  L Repetto; P G Giannessi; E Campora; P Pronzato; A Vigani; C Naso; I Spinelli; P F Conte; R Rosso
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 3.  Potential uses of interferon alpha 2 as adjuvant therapy in cancer.

Authors:  S S Agarwala; J M Kirkwood
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.